Supplementary Figure S3 from Targeting CDK7 Enhances the Antitumor Efficacy of Enzalutamide in Androgen Receptor–Positive Triple-Negative Breast Cancer by Inhibiting c-MYC–mediated Tumorigenesis
Year: 2025
Type: supplementary-materials
Abstract: Supplementary Figure S3. No significant correlation was found between expression levels of AR and CDK7 in either primary breast tumors or TNBC.
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4411039354